Hans S. Schroder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hans S. Schroder has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Jason S. Moser
Department of Psychology, Michigan State University, East Lansing, MI, United States
5 shared publications- Elizabeth T. Kneeland
Amherst College
3 shared publications - Diego A. Pizzagalli
Noel Drury, M.D. Institute for Translational Depression Discoveries, University of California, Irvine, USA
2 shared publications Kate D. Fitzgerald
Department of Psychiatry University of Michigan Medical School Ann Arbor Michigan USA
2 shared publications- Micah Breiger
McLean Hospital/Harvard Medical School, Boston, MA
2 shared publications - Sarah Bommarito
Department of Psychiatry, University of Michigan Medical School, USA
2 shared publications
Latest Publications
- 30 July 2026
- Published by Cambridge University Press (CUP) in Philosophy of Science
- p. 1-14
An ambiguity in the notion of a “biomedical” approach to mental health
Over the past 50 years, psychological research has examined the stigma associated with “biomedical” models of mental illness. Credited with reducing blameworthiness, such models are also linked to negative outcomes such as prognostic pessimism and the desire for social distance. We argue that this research is hindered by an ambiguity in the notion of a “biomedical” framing, which conflates two ideas: a dysfunction-centered framing and a biogenic framing. We disentangle these concepts and highlight evidence that the dysfunction component of the biomedical framing, rather than the biogenic component, drives the observed negative outcomes. We discuss implications for research and practice.
- 30 July 2026
- Published by Cambridge University Press (CUP) in Philosophy of Science
- p. 1-14
An ambiguity in the notion of a “biomedical” approach to mental health
Over the past 50 years, psychological research has examined the stigma associated with “biomedical” models of mental illness. Credited with reducing blameworthiness, such models are also linked to negative outcomes such as prognostic pessimism and the desire for social distance. We argue that this research is hindered by an ambiguity in the notion of a “biomedical” framing, which conflates two ideas: a dysfunction-centered framing and a biogenic framing. We disentangle these concepts and highlight evidence that the dysfunction component of the biomedical framing, rather than the biogenic component, drives the observed negative outcomes. We discuss implications for research and practice.
- 19 December 2025
- Published by Elsevier in Patient Education and Counseling
- Vol. 144, 109463
Medical providers and biogenetic messages about depression: A vignette experiment
- 19 December 2025
- Published by Elsevier in Patient Education and Counseling
- Vol. 144, 109463
Medical providers and biogenetic messages about depression: A vignette experiment
- Open Access
- 8 January 2025
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 15, 1469913
Where do “chemical imbalance” beliefs come from? Evaluating the impact of different sources
Introduction: Although the etiology of depression is incredibly complex, the narrative that it is caused by a simple “chemical imbalance” persists in lay settings. We sought to understand where people are exposed to this explanation (i.e., the “source”), and the relative influence of each source.Methods: A total of 1,219 college students were asked where they had heard of the chemical imbalance explanation and how much they believed this to be true. Independent raters coded open-ended responses and we used self-report measures to capture chemical imbalance belief endorsement.Results: The most common sources of exposure to this explanation were the classroom, the Internet/media, other people (e.g., friends), and healthcare providers. In a regression analysis, only learning about the chemical imbalance explanation from healthcare providers uniquely predicted the adoption of the chemical imbalance belief. The correlation held even after controlling for depression symptoms, a family history of depression, and having had a diagnosis or treatment of mental health disorder (all of which also uniquely predicted chemical imbalance belief endorsement).Discussion: These results suggest that healthcare providers play an important role in the dissemination of the chemical imbalance message, which is an oversimplified, scientifically controversial, and potentially treatment-interfering narrative. Interventions directed at healthcare providers may help them engage with more accurate messages.
- 8 January 2025
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 15, 1469913
Open AccessWhere do “chemical imbalance” beliefs come from? Evaluating the impact of different sources
Introduction: Although the etiology of depression is incredibly complex, the narrative that it is caused by a simple “chemical imbalance” persists in lay settings. We sought to understand where people are exposed to this explanation (i.e., the “source”), and the relative influence of each source.Methods: A total of 1,219 college students were asked where they had heard of the chemical imbalance explanation and how much they believed this to be true. Independent raters coded open-ended responses and we used self-report measures to capture chemical imbalance belief endorsement.Results: The most common sources of exposure to this explanation were the classroom, the Internet/media, other people (e.g., friends), and healthcare providers. In a regression analysis, only learning about the chemical imbalance explanation from healthcare providers uniquely predicted the adoption of the chemical imbalance belief. The correlation held even after controlling for depression symptoms, a family history of depression, and having had a diagnosis or treatment of mental health disorder (all of which also uniquely predicted chemical imbalance belief endorsement).Discussion: These results suggest that healthcare providers play an important role in the dissemination of the chemical imbalance message, which is an oversimplified, scientifically controversial, and potentially treatment-interfering narrative. Interventions directed at healthcare providers may help them engage with more accurate messages.
- Open Access
- 1 January 2025
- Published by Elsevier in SSRN Electronic Journal
Medical providers and biogenetic messages about depression A vignette experiment
Objectives: Healthcare providers play an important role in educating patients about the causes of their problems. Certain narratives, such as the chemical imbalance explanation of depression, are overly simplistic and may have negative impacts on stigma and hope for recovery. However, no previous studies have surveyed medical providers on their use of biogenetic messaging to patients, nor has any research studied the conditions under which these messages are more likely to be invoked. Methods: In this online, pre-registered vignette experiment, we randomized 396 medical providers (physicians and medical students) to read one of two vignettes of a woman experiencing significant depressive symptoms: one in which her depression was precipitated by a significant loss and one in which no clear cause for depression was provided. Results: In line with our hypotheses, providers exposed to the “no-trigger” vignette were more likely to focus their conversation using biogenetic language. Exploratory analyses revealed that the tendency to use biogenetic language was also correlated with efforts to reduce patient blame. Conclusions: Healthcare providers are more likely to use biogenetic narratives when the cause of a patient’s depression is unknown. Practice implications: Clinicians should be mindful of the lure of biogenetic messaging, especially when the cause of depression is unclear.
- 1 January 2025
- Published by Elsevier in SSRN Electronic Journal
Open AccessMedical providers and biogenetic messages about depression A vignette experiment
Objectives: Healthcare providers play an important role in educating patients about the causes of their problems. Certain narratives, such as the chemical imbalance explanation of depression, are overly simplistic and may have negative impacts on stigma and hope for recovery. However, no previous studies have surveyed medical providers on their use of biogenetic messaging to patients, nor has any research studied the conditions under which these messages are more likely to be invoked. Methods: In this online, pre-registered vignette experiment, we randomized 396 medical providers (physicians and medical students) to read one of two vignettes of a woman experiencing significant depressive symptoms: one in which her depression was precipitated by a significant loss and one in which no clear cause for depression was provided. Results: In line with our hypotheses, providers exposed to the “no-trigger” vignette were more likely to focus their conversation using biogenetic language. Exploratory analyses revealed that the tendency to use biogenetic language was also correlated with efforts to reduce patient blame. Conclusions: Healthcare providers are more likely to use biogenetic narratives when the cause of a patient’s depression is unknown. Practice implications: Clinicians should be mindful of the lure of biogenetic messaging, especially when the cause of depression is unclear.
- 22 June 2024
- Published by Springer Nature in Cognitive Therapy and Research
- Vol. 48 (6) , 1152-1159
The Relationship Between Emotion Malleability Beliefs and Suicidal Ideation or Behaviors
- 22 June 2024
- Published by Springer Nature in Cognitive Therapy and Research
- Vol. 48 (6) , 1152-1159
The Relationship Between Emotion Malleability Beliefs and Suicidal Ideation or Behaviors
- 8 June 2024
- Published by Elsevier in Journal of Behavioral and Cognitive Therapy
- Vol. 34 (2)
Using biogenetic beliefs as an emotion regulation strategy
- 8 June 2024
- Published by Elsevier in Journal of Behavioral and Cognitive Therapy
- Vol. 34 (2)
Using biogenetic beliefs as an emotion regulation strategy
- 3 June 2023
- Published by Elsevier in Social Science & Medicine
- Vol. 328, 115995
Framing depression as a functional signal, not a disease: Rationale and initial randomized controlled trial
- 3 June 2023
- Published by Elsevier in Social Science & Medicine
- Vol. 328, 115995
Framing depression as a functional signal, not a disease: Rationale and initial randomized controlled trial
- 3 March 2023
- Published by Springer Nature in Cognitive, Affective, & Behavioral Neuroscience
- Vol. 23 (2) , 383-399
Limited impacts of biogenetic messaging on neural correlates of cognitive control and beliefs about depression
During the past 60 years, perceptions about the origins of mental illness have shifted toward a biomedical model, depicting depression as a biological disorder caused by genetic abnormalities and/or chemical imbalances. Despite benevolent intentions to reduce stigma, biogenetic messages promote prognostic pessimism, reduce feelings of agency, and alter treatment preferences, motivations, and expectations. However, no research has examined how these messages influence neural markers of ruminative activity or decision-making, a gap this study sought to fill. In this pre-registered, clinical trial (NCT03998748), 49 participants with current or past depressive experiences completed a sham saliva test and were randomly assigned to receive feedback that they either have (gene-present; n = 24) or do not have (gene-absent; n = 25) a genetic predisposition to depression. Before and after receiving the feedback, resting-state activity and neural correlates of cognitive control (error-related negativity [ERN] and error positivity [Pe]) were measured using high-density electroencephalogram (EEG). Participants also completed self-report measures of beliefs about the malleability and prognosis of depression and treatment motivation. Contrary to hypotheses, biogenetic feedback did not alter perceptions or beliefs about depression, nor did it alter EEG markers of self-directed rumination nor neurophysiological correlates of cognitive control. Explanations of these null findings are discussed in the context of prior studies.
- 3 March 2023
- Published by Springer Nature in Cognitive, Affective, & Behavioral Neuroscience
- Vol. 23 (2) , 383-399
Limited impacts of biogenetic messaging on neural correlates of cognitive control and beliefs about depression
During the past 60 years, perceptions about the origins of mental illness have shifted toward a biomedical model, depicting depression as a biological disorder caused by genetic abnormalities and/or chemical imbalances. Despite benevolent intentions to reduce stigma, biogenetic messages promote prognostic pessimism, reduce feelings of agency, and alter treatment preferences, motivations, and expectations. However, no research has examined how these messages influence neural markers of ruminative activity or decision-making, a gap this study sought to fill. In this pre-registered, clinical trial (NCT03998748), 49 participants with current or past depressive experiences completed a sham saliva test and were randomly assigned to receive feedback that they either have (gene-present; n = 24) or do not have (gene-absent; n = 25) a genetic predisposition to depression. Before and after receiving the feedback, resting-state activity and neural correlates of cognitive control (error-related negativity [ERN] and error positivity [Pe]) were measured using high-density electroencephalogram (EEG). Participants also completed self-report measures of beliefs about the malleability and prognosis of depression and treatment motivation. Contrary to hypotheses, biogenetic feedback did not alter perceptions or beliefs about depression, nor did it alter EEG markers of self-directed rumination nor neurophysiological correlates of cognitive control. Explanations of these null findings are discussed in the context of prior studies.
- 14 July 2022
- Published by Taylor & Francis in Journal of American College Health
- Vol. 72 (7) , 1993-2000
Chemical imbalance and etiological beliefs about depression among college students
Etiological beliefs of depression have differing impacts on motivation, hope, and treatment expectations. However, it is unclear where people are exposed to these beliefs. Objective: This study examined beliefs about depression and their relations to symptoms, attitudes about depression, and treatment preferences. Participants: 426 undergraduates attending a large midwestern university. Methods: Participants completed an online survey asking about causes of depression, if and where they had heard about the “chemical imbalance” explanation of depression, attitudes about depression, as well as measures of their symptoms, treatment history, and hypothetical treatment preferences. Results: Sixty-two percent of the sample had hard of the chemical imbalance explanation, most commonly from the classroom. Biochemical beliefs about depression were most strongly endorsed among participants with a family history of depression and who had had personal experience with treatment. The chemical imbalance belief was uniquely related to dysfunctional beliefs about depression. Etiological beliefs were largely unrelated to treatment preferences. Conclusion: College students are exposed to models of mental health that may not be ideal for treatment and recovery.
- 14 July 2022
- Published by Taylor & Francis in Journal of American College Health
- Vol. 72 (7) , 1993-2000
Chemical imbalance and etiological beliefs about depression among college students
Etiological beliefs of depression have differing impacts on motivation, hope, and treatment expectations. However, it is unclear where people are exposed to these beliefs. Objective: This study examined beliefs about depression and their relations to symptoms, attitudes about depression, and treatment preferences. Participants: 426 undergraduates attending a large midwestern university. Methods: Participants completed an online survey asking about causes of depression, if and where they had heard about the “chemical imbalance” explanation of depression, attitudes about depression, as well as measures of their symptoms, treatment history, and hypothetical treatment preferences. Results: Sixty-two percent of the sample had hard of the chemical imbalance explanation, most commonly from the classroom. Biochemical beliefs about depression were most strongly endorsed among participants with a family history of depression and who had had personal experience with treatment. The chemical imbalance belief was uniquely related to dysfunctional beliefs about depression. Etiological beliefs were largely unrelated to treatment preferences. Conclusion: College students are exposed to models of mental health that may not be ideal for treatment and recovery.
- 16 June 2022
- Published by Wiley in Depression and Anxiety
- Vol. 39 (8-9) , 646-656
Targeting cognitive control to reduce anxiety in very young children: A proof of concept study
Underdeveloped cognitive control (CC)-the capacity to flexibly adjust to changing environments-may predispose some children to early onset anxiety disorders and represents a promising intervention target. The current study established and pilot-tested "Camp Kidpower"-a novel group-based, interactive CC training intervention-and assessed its impacts on behavioral and neurophysiological indices of CC among preschool children with elevated anxiety symptoms. Forty-four anxious children (4-6 years) were enrolled in Camp Kidpower, delivered in four sessions over 10 days. Before and after camp, children's capacity for CC was measured using well-validated, non-trained behavioral tasks and error-related negativity (ERN). Child anxiety symptoms were measured by parent report on the Spence Preschool Anxiety Scale. Thirty-two children completed the study, as defined by completion of pre- and follow-up assessments and at least three camp sessions. From baseline to after camp, performance on behavioral tests of CC improved, ERN amplitude increased, and anxiety symptoms decreased. Results provide initial evidence that play-based cognitive training targeted to behavioral and brain markers of CC reduces anxiety in preschoolers.
- 16 June 2022
- Published by Wiley in Depression and Anxiety
- Vol. 39 (8-9) , 646-656
Targeting cognitive control to reduce anxiety in very young children: A proof of concept study
Underdeveloped cognitive control (CC)-the capacity to flexibly adjust to changing environments-may predispose some children to early onset anxiety disorders and represents a promising intervention target. The current study established and pilot-tested "Camp Kidpower"-a novel group-based, interactive CC training intervention-and assessed its impacts on behavioral and neurophysiological indices of CC among preschool children with elevated anxiety symptoms. Forty-four anxious children (4-6 years) were enrolled in Camp Kidpower, delivered in four sessions over 10 days. Before and after camp, children's capacity for CC was measured using well-validated, non-trained behavioral tasks and error-related negativity (ERN). Child anxiety symptoms were measured by parent report on the Spence Preschool Anxiety Scale. Thirty-two children completed the study, as defined by completion of pre- and follow-up assessments and at least three camp sessions. From baseline to after camp, performance on behavioral tests of CC improved, ERN amplitude increased, and anxiety symptoms decreased. Results provide initial evidence that play-based cognitive training targeted to behavioral and brain markers of CC reduces anxiety in preschoolers.